<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03200054</url>
  </required_header>
  <id_info>
    <org_study_id>195/2015</org_study_id>
    <nct_id>NCT03200054</nct_id>
  </id_info>
  <brief_title>Postpartum Adherence Clubs for Antiretroviral Therapy</brief_title>
  <acronym>PACART</acronym>
  <official_title>Postpartum Adherence Clubs for Antiretroviral Therapy: a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cape Town</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cape Town</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      South Africa is implementing the policy of universal initiation of lifelong antiretroviral
      therapy (ART) in all HIV-infected pregnant women regardless of CD4 cell count or disease
      stage (&quot;Option B+&quot;). There is a recognised need for innovative models of service delivery to
      support adherence and retention in care in this group, particularly during the postpartum
      period. The investigators are conducting a pragmatic randomised control trial to compare
      virological outcomes 24 months postpartum in two models of service delivery for provision of
      HIV care and treatment services postpartum in women who initiated ART during pregnancy: local
      adult ART clinics and community-based adherence clubs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      South Africa is implementing the policy of universal initiation of lifelong ART in all
      HIV-infected pregnant women regardless of CD4 cell count or disease stage (&quot;Option B+&quot;) and
      given the high antenatal HIV seroprevalence, HIV-infected pregnant women represent the
      largest group of patients initiating ART in primary care facilities. However, there are few
      well developed models of service delivery to support implementation. There are particular
      concerns regarding the postpartum period, with multiple studies indicating high levels of
      non-retention in care and/or inadequate adherence to treatment postnatally. Adherence Clubs
      (ACs) are an innovative but untested model of care based on chronic disease management
      strategies that emphasize social support, adherence to treatment and retention in care,
      rather than intensive clinical management, as the most important determinant of long-term
      health outcomes in stable patients in chronic care. ACs have preliminarily been shown to to
      result in virologic outcomes that are similar to routine clinic services in patients stable
      on ART. The investigators are conducting a pragmatic, randomised controlled trial to evaluate
      two different strategies for delivering HIV care and treatment services during the postpartum
      period to HIV-infected women who initiated ART during pregnancy. Participants will be
      allocated to receive ART care at either local adult ART clinics, following the current
      standard of care, or the community-based adherence club system.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Viral suppression</measure>
    <time_frame>24 months</time_frame>
    <description>Viral load &lt;50 copies per ml up to 24 month visit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal retention in care</measure>
    <time_frame>24 months</time_frame>
    <description>Missed routinely scheduled clinical care visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal death</measure>
    <time_frame>24 months</time_frame>
    <description>Maternal deaths over the study period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal mental health</measure>
    <time_frame>24 months</time_frame>
    <description>Mental health as assessed via brief screening tools (Edinburgh Postnatal Depression Scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal health care service use</measure>
    <time_frame>24 months</time_frame>
    <description>Use of health facilities including hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant death</measure>
    <time_frame>24 months</time_frame>
    <description>Infant deaths over the study period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant health care service use</measure>
    <time_frame>24 months</time_frame>
    <description>Use of health facilities including hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant HIV testing</measure>
    <time_frame>24 months</time_frame>
    <description>Uptake of routine infant HIV testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant HIV infection</measure>
    <time_frame>24 months</time_frame>
    <description>Mother-to-child transmission of HIV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant feeding</measure>
    <time_frame>24 months</time_frame>
    <description>Breastfeeding practices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost and cost-effectiveness</measure>
    <time_frame>24 months</time_frame>
    <description>Cost-effectiveness of each strategy will be analysed from both the patient and health systems perspective</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability of each ART service</measure>
    <time_frame>24 months</time_frame>
    <description>Acceptability of each service will be assessed using the patient-provider interview schedule, and qualitative interviews will be done on a subset of participants</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">388</enrollment>
  <condition>Hiv</condition>
  <arm_group>
    <arm_group_label>Clinic-based Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Clinic-based care is the current standard of care and is defined as referral of women on antiretroviral therapy (ART) to general primary care adult ART services.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adherence Club Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adherence club care involves referral of women on ART to community-based ART services in the form of adherence clubs, which are led by community health workers and supported by ART clinic nurses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adherence Clubs</intervention_name>
    <description>Women will be referred to the ACs at their postpartum ART clinic visit at the midwife obstetric unit (MOU) at the Gugulethu community health centre (CHC). AC visits occur 2-4 monthly at a community hall near the CHC. At routine visits, which last ~1 hour, community health workers provide health education, weigh participants, ask about symptoms, and dispense pre-packed ART. Symptomatic participants are referred back to the main ART facility at the CHC for assessment by a nurse. A nurse performs routine phlebotomy at an annual club visit, and does a clinical assessment and reviews blood results at the subsequent visit. Participants requiring more regular follow-up and those with raised viral loads are referred back to the ART clinic at the CHC by the nurse.</description>
    <arm_group_label>Adherence Club Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented HIV infection with ART initiation during the preceding antenatal period

          -  Within 70 days post-delivery

          -  Viral suppression documented in pregnancy with the most recent viral load &lt;400
             copies/mL within the last 3 months

          -  Willingness to be randomised and return for study measurement visits

          -  Able and willing to attend service visits at either a local ART treatment centre or
             the adherence club at Ikhwezi centre

          -  Able to provide informed consent for research

        Exclusion Criteria:

          -  Intention to relocate out of Cape Town permanently during the study period

          -  Any medical, psychiatric or social condition which in the opinion of the investigators
             would affect the ability to consent and/or participate in the study including: refusal
             to take ART/antiretrovirals (ARVs) and/or denial of HIV status

          -  Loss of pregnancy/neonate at the time of eligibility determination

          -  Current co-morbidity requiring additional health care attention, including
             opportunistic infections such as tuberculosis (TB) disease or any chronic condition or
             other condition that is not controlled or stable
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Landon Myer, MBChB PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cape Town</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jasantha Odayar, MBChB</last_name>
    <phone>+27 21 406 6713</phone>
    <email>jasanthaodayar@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bupe Mwambe, BA</last_name>
    <phone>+27 21 406 6713</phone>
    <email>MWMBUP001@myuct.ac.za</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gugulethu Community Health Centre</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7750</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasantha Odayar, MBChB</last_name>
      <phone>+2721 406 6713</phone>
      <email>jasanthaodayar@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Bupe Mwamba, BA</last_name>
      <phone>+2721 406 6713</phone>
      <email>MWMBUP001@myuct.ac.za</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <reference>
    <citation>Kaplan R, Orrell C, Zwane E, Bekker LG, Wood R. Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS. 2008 Aug 20;22(13):1679-81. doi: 10.1097/QAD.0b013e32830ebcee.</citation>
    <PMID>18670232</PMID>
  </reference>
  <reference>
    <citation>Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, Mills EJ, Ho YS, Stringer JS, McIntyre JA, Mofenson LM. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012 Oct 23;26(16):2039-52. doi: 10.1097/QAD.0b013e328359590f. Review.</citation>
    <PMID>22951634</PMID>
  </reference>
  <reference>
    <citation>Coutsoudis A, Goga A, Desmond C, Barron P, Black V, Coovadia H. Is Option B+ the best choice? Lancet. 2013 Jan 26;381(9863):269-71. doi: 10.1016/S0140-6736(12)61807-8.</citation>
    <PMID>23351797</PMID>
  </reference>
  <reference>
    <citation>Chi BH, Stringer JS, Moodley D. Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan Africa. Curr HIV/AIDS Rep. 2013 Jun;10(2):124-33. doi: 10.1007/s11904-013-0154-z. Review.</citation>
    <PMID>23440538</PMID>
  </reference>
  <reference>
    <citation>Luque-Fernandez MA, Van Cutsem G, Goemaere E, Hilderbrand K, Schomaker M, Mantangana N, Mathee S, Dubula V, Ford N, Hern√°n MA, Boulle A. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One. 2013;8(2):e56088. doi: 10.1371/journal.pone.0056088. Epub 2013 Feb 13.</citation>
    <PMID>23418518</PMID>
  </reference>
  <reference>
    <citation>Provincial Government of the Western Cape. PMTCT Clinical Guidelines Update, May 2013. Cape Town: PGWC; 2013.</citation>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>June 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2017</study_first_posted>
  <last_update_submitted>July 5, 2017</last_update_submitted>
  <last_update_submitted_qc>July 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cape Town</investigator_affiliation>
    <investigator_full_name>Professor Landon Myer</investigator_full_name>
    <investigator_title>Head: Department of Public Health and Family Medicine</investigator_title>
  </responsible_party>
  <keyword>therapy</keyword>
  <keyword>postnatal</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

